KLF2 is a zinc finger transcription factor that contributes to the regulation of cell differentiation, proliferation, apoptosis, and inflammation.
– In breast cancer(and CRC), several studies have reported that KLF2 expression is decreased in more aggressive tumor subtypes.
– Reduced KLF2 levels are often associated with enhanced cell proliferation, migration, and invasion, which may contribute to a worse prognosis.
(Will delete Record if Target field = "Delete") Home